Hainan Haiyao Co., Ltd (SHE: 000566), a prominent Chinese company, has announced the signing of an initial joint venture (JV) agreement with the Haikou National High-tech Industrial Development Zone Management Committee and Xenios AG, a subsidiary of German healthcare giant Fresenius Medical Care AG. This strategic collaboration is aimed at developing and producing long-acting and short-acting membrane oxygenators, arteriovenous catheters, and other ECMO (extracorporeal membrane oxygenation) compatible products.
Investment and Stake Distribution
In a significant financial commitment, Haiyao will invest RMB 200 million to secure a 45% stake in the JV, with the Haikou National High-tech Industrial Development Zone holding a share of this investment. Xenios AG, known for its expertise in developing extracorporeal cardiopulmonary support assistive devices, will own a 40% stake in the new venture, highlighting the importance of this partnership for both parties.-Fineline Info & Tech
